ROME, 15 Mar – RIA Novosti, Alexander Logunov. The banned batch of AstraZeneca vaccine in Italy is 250,000 doses, said Giorgio Palu, President of the Italian Medicines Agency (Aifa).
The well-known virologist stressed that upon completion of the tests, the batch of the drug will again receive permission.
Three deaths shortly after vaccination against coronavirus infection using the drug AstraZeneca were recorded in Sicily. They are being studied by the Italian investigative authorities. Last week, Aifa announced that it has banned the use in the country of doses from the batch ABV2856 “as a precautionary measure” pending clarification of all circumstances. Prime Minister Mario Draghi later pointed out that Italian medical authorities found no evidence of a link between the use of this vaccine and the death of several citizens. The use of the vaccine from the British-Swedish company from its other parties in Italy continues. “This is a batch of 500 thousand doses, of which 250 thousand were delivered to Italy, and 170 thousand were administered without serious side effects. Every year, thromboembolism (blockage of blood vessels ) affects about one person per thousand inhabitants. Among young people, this figure rises to one case per 10-100 thousand inhabitants, “said the head of Aifa.
The fear of vaccinations and unsubstantiated claims threaten the strategy to combat coronavirus infection, he said. “The vaccines are safe, just look at the numbers. AstraZeneca has been administered to 11 million people in the UK. There have been 269 thromboembolisms after use, of which 45 were fatal. However, they are related to vaccination only in time, no direct cause has been found,” the expert said. …
Recently, EU countries have received another large batch of Oxford vaccine from AstraZeneca, in particular, a batch of ABV5300 has been shipped to 17 countries. The authorities in Austria, Estonia, Lithuania, Latvia and Luxembourg decided to suspend the use of doses from this consignment as a precautionary measure. Denmark, Norway and Iceland, and later the Netherlands, also suspended the drug on Thursday. Bulgaria did the same on Friday. The authorities in Italy and Romania made a similar decision regarding doses from the ABV2856 batch.
European Medicines Regulator – The European Medicines Agency (EMA) announced that it is continuing to investigate incidents of patients who received the vaccine from the same batch of AstraZeneca vaccine in several EU countries and who later had thromboembolic complications, but still believes that so far there is no indication that the vaccine could have caused these conditions.